Yes, methamphetamine is a stimulant. It is classified as a powerful central nervous system (CNS) stimulant and remains one of the most addictive substances encountered in both clinical and community settings. The U.S. Drug Enforcement Administration lists it as a Schedule II controlled substance, meaning it has a high potential for misuse but does have a narrow, FDA-approved medical use.
What Makes It a Stimulant
Stimulants are drugs that speed up activity in the brain and nervous system. Methamphetamine does this by forcing nerve cells to release large amounts of dopamine, the chemical messenger tied to pleasure, motivation, and movement. It acts on both the transporters that move dopamine across cell membranes and the internal storage compartments that hold dopamine inside nerve endings, creating a massive flood of the chemical into the spaces between brain cells.
Compared to regular amphetamine (the active ingredient in many ADHD medications), methamphetamine is more fat-soluble. That chemical property allows it to cross from the bloodstream into the brain more efficiently, which is one reason its effects hit harder and last longer. The average half-life of methamphetamine is about 10 hours, meaning it takes roughly that long for the body to clear just half of a single dose. For comparison, standard amphetamine’s half-life is closer to 10 to 13 hours depending on the formulation, but methamphetamine’s greater brain penetration produces a more intense subjective high at equivalent doses.
Short-Term Effects on the Body
Because methamphetamine activates the body’s fight-or-flight response, the immediate physical effects include a rapid heart rate, elevated blood pressure, constricted blood vessels, widened airways, and a spike in blood sugar. Users also experience a rise in body temperature. These are hallmark stimulant effects, the same category of responses you’d see with cocaine or high doses of prescription amphetamines, just more pronounced and longer lasting.
At low to moderate doses (roughly 5 to 30 mg, the range used in clinical settings), the drug produces arousal, improved mood, and short-term boosts in attention and coordination. At the doses typically used illicitly, often 50 mg or more, the effects become far more dangerous and unpredictable.
Short-Term Effects on the Mind
The psychological side of the stimulant effect is what drives repeated use. Methamphetamine produces intense euphoria, a surge of energy and alertness, heightened emotions, decreased anxiety, and inflated self-esteem. Users often describe feeling invincible or extraordinarily focused. These effects can last for hours given the drug’s long half-life, which is part of what makes “binge” patterns of use so common. People stay awake for days, redosing to maintain the high.
Long-Term Damage to the Brain
The same mechanism that produces euphoria also causes lasting harm. Repeated flooding of dopamine into nerve terminals damages and eventually destroys those terminals, particularly in the striatum, a brain region critical for movement, motivation, and habit formation. Animal studies show swollen and distorted nerve fibers after heavy exposure, and there is evidence that the damage can extend beyond the nerve endings back to the cell bodies themselves, a pattern researchers compare to the “dying back” process seen in Parkinson’s disease. Chronic methamphetamine use is associated with an increased risk of developing Parkinson’s later in life.
People who use methamphetamine over months or years show measurable deficits in memory and executive functioning, the mental skills involved in planning, decision-making, and impulse control. Rates of anxiety and depression climb significantly.
The most striking long-term psychiatric effect is psychosis. Methamphetamine-induced psychosis closely resembles schizophrenia, with persecutory delusions and auditory hallucinations being the most common symptoms. One particularly characteristic feature is formication: the unshakable belief that bugs are crawling on or under the skin, which leads to compulsive scratching and visible skin sores. Another unusual behavior is “punding,” a pattern of repetitive, purposeless activity like disassembling and reassembling objects for hours. These psychiatric symptoms can persist for months after a person stops using the drug, likely reflecting the underlying neurotoxic damage.
Cardiovascular Risks
The stimulant properties of methamphetamine place enormous strain on the heart and blood vessels. Chronic use is linked to high blood pressure, coronary artery disease, thickening of the heart’s left ventricle, and blood vessel spasms. What makes these findings alarming is the age of the patients: cardiovascular complications that typically appear in older adults are showing up in younger methamphetamine users. The drug’s effect on arteries promotes inflammation and the buildup of fatty plaques, accelerating the kind of arterial damage that leads to heart attacks and strokes.
Withdrawal and What It Looks Like
When someone who has been using methamphetamine regularly stops abruptly, the withdrawal syndrome is essentially the opposite of stimulation. The acute phase lasts 7 to 10 days and features depressed mood, anxiety, and significant sleep disturbance. Many people sleep for extended periods as the body tries to recover from prolonged wakefulness. Residual symptoms tied to neurotoxic damage, including cognitive fog and emotional blunting, can linger for several months.
The Prescription Form
Methamphetamine does have one FDA-approved use. A prescription formulation called Desoxyn is approved for treating ADHD in children aged 6 and older. The recommended dosage range tops out at 20 to 25 mg per day, starting at just 5 mg once or twice daily. At these controlled, low doses, the drug improves attention without producing the intense euphoria associated with illicit use. It is rarely prescribed in practice, used only when other ADHD medications have failed. Its existence as a Schedule II drug, rather than Schedule I, reflects this limited medical application.